Turcot Syndrome Latest Advances

Metachronous colon cancer after successful treatment of mismatch repair-deficient metastatic colorectal cancer

Journal: Ugeskrift for laeger

Published: November 28, 2025

A missed opportunity for preventing CMMRD: is it time to include Lynch syndrome genes in prenatal genetic testing?

Journal: BMJ case reports

Published: November 12, 2025

Incidence of Mismatch Repair Deficiency in Rectal Cancer and Response to Neoadjuvant Treatment.

Journal: Clinical colorectal cancer

Published: August 13, 2025

Mismatch Repair Cancer Syndrome presenting as synchronous high-grade glioma and diffuse large B cell lymphoma in a pediatric patient.

Journal: Cancer genetics

Published: June 07, 2025

PMS2-related constitutional mismatch repair deficiency in a patient with unilateral retinoblastoma and negative germline RB1.

Journal: Ophthalmic genetics

Published: May 26, 2025

Molecular characteristics by race and ethnicity of patients with high tumor mutational burden, high microsatellite instability, and mismatch repair deficiency: Real-world data from the multi-institutional Endometrial cancer Molecularly Targeted Therapy Consortium (ECMT2).

Journal: Gynecologic oncology

Published: April 21, 2025

Patterns of primary metastasis and recurrence in mismatch repair deficiency and p53 abnormal endometrial carcinoma.

Journal: Gynecologic oncology

Published: March 20, 2025

Advances in constitutional mismatch repair deficiency syndrome associated tumors

Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology

Published: March 03, 2025

Association of endometrial cancer epigenetic mismatch repair deficiency with clinicopathologic factors and survival in a large, diverse community-based cohort.

Journal: Gynecologic oncology

Published: February 27, 2025

Prevalence of Atypical and Subclonal p53 Immunohistochemistry Expression in Mismatch Repair Deficient and/or POLE-Mutant Endometrial Carcinomas with TP53 Mutation.

Journal: Laboratory investigation; a journal of technical methods and pathology

Published: January 28, 2025

NTRK gene fusion and molecular pathological characteristics of mismatch repair deficient colorectal cancer

Journal: Zhonghua bing li xue za zhi = Chinese journal of pathology

Published: January 25, 2025

Frequency and Impact of Constitutional Mismatch Repair Deficiency in Patients With High-Grade Glioma, a Retrospective Analysis of 7 Years in Pakistan: an IRRDC Study.

Journal: JCO global oncology

Published: January 17, 2025

Filters

Metachronous colon cancer after successful treatment of mismatch repair-deficient metastatic colorectal cancer

Metachronous colon cancer after successful treatment of mismatch repair-deficient metastatic colorectal cancer

A missed opportunity for preventing CMMRD: is it time to include Lynch syndrome genes in prenatal genetic testing?

A missed opportunity for preventing CMMRD: is it time to include Lynch syndrome genes in prenatal genetic testing?

Incidence of Mismatch Repair Deficiency in Rectal Cancer and Response to Neoadjuvant Treatment.

Incidence of Mismatch Repair Deficiency in Rectal Cancer and Response to Neoadjuvant Treatment.

Mismatch Repair Cancer Syndrome presenting as synchronous high-grade glioma and diffuse large B cell lymphoma in a pediatric patient.

Mismatch Repair Cancer Syndrome presenting as synchronous high-grade glioma and diffuse large B cell lymphoma in a pediatric patient.

PMS2-related constitutional mismatch repair deficiency in a patient with unilateral retinoblastoma and negative germline RB1.

PMS2-related constitutional mismatch repair deficiency in a patient with unilateral retinoblastoma and negative germline RB1.

Molecular characteristics by race and ethnicity of patients with high tumor mutational burden, high microsatellite instability, and mismatch repair deficiency: Real-world data from the multi-institutional Endometrial cancer Molecularly Targeted Therapy Consortium (ECMT2).

Molecular characteristics by race and ethnicity of patients with high tumor mutational burden, high microsatellite instability, and mismatch repair deficiency: Real-world data from the multi-institutional Endometrial cancer Molecularly Targeted Therapy Consortium (ECMT2).

Patterns of primary metastasis and recurrence in mismatch repair deficiency and p53 abnormal endometrial carcinoma.

Patterns of primary metastasis and recurrence in mismatch repair deficiency and p53 abnormal endometrial carcinoma.

Advances in constitutional mismatch repair deficiency syndrome associated tumors

Advances in constitutional mismatch repair deficiency syndrome associated tumors

Association of endometrial cancer epigenetic mismatch repair deficiency with clinicopathologic factors and survival in a large, diverse community-based cohort.

Association of endometrial cancer epigenetic mismatch repair deficiency with clinicopathologic factors and survival in a large, diverse community-based cohort.

Prevalence of Atypical and Subclonal p53 Immunohistochemistry Expression in Mismatch Repair Deficient and/or POLE-Mutant Endometrial Carcinomas with TP53 Mutation.

Prevalence of Atypical and Subclonal p53 Immunohistochemistry Expression in Mismatch Repair Deficient and/or POLE-Mutant Endometrial Carcinomas with TP53 Mutation.

NTRK gene fusion and molecular pathological characteristics of mismatch repair deficient colorectal cancer

NTRK gene fusion and molecular pathological characteristics of mismatch repair deficient colorectal cancer

Frequency and Impact of Constitutional Mismatch Repair Deficiency in Patients With High-Grade Glioma, a Retrospective Analysis of 7 Years in Pakistan: an IRRDC Study.

Frequency and Impact of Constitutional Mismatch Repair Deficiency in Patients With High-Grade Glioma, a Retrospective Analysis of 7 Years in Pakistan: an IRRDC Study.